Ameritas Investment Partners’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $264K | Hold |
9,174
| – | – | 0.01% | 1141 |
|
2025
Q1 | $308K | Hold |
9,174
| – | – | 0.01% | 1031 |
|
2024
Q4 | $469K | Buy |
9,174
+1,291
| +16% | +$66K | 0.02% | 864 |
|
2024
Q3 | $403K | Buy |
7,883
+260
| +3% | +$13.3K | 0.01% | 922 |
|
2024
Q2 | $341K | Buy |
7,623
+864
| +13% | +$38.7K | 0.01% | 955 |
|
2024
Q1 | $316K | Hold |
6,759
| – | – | 0.01% | 1003 |
|
2023
Q4 | $240K | Buy |
6,759
+282
| +4% | +$10K | 0.01% | 1154 |
|
2023
Q3 | $193K | Buy |
6,477
+2,490
| +62% | +$74.1K | 0.01% | 1200 |
|
2023
Q2 | $71.8K | Hold |
3,987
| – | – | ﹤0.01% | 1814 |
|
2023
Q1 | $64K | Hold |
3,987
| – | – | ﹤0.01% | 1822 |
|
2022
Q4 | $79.3K | Hold |
3,987
| – | – | ﹤0.01% | 1751 |
|
2022
Q3 | $78K | Hold |
3,987
| – | – | ﹤0.01% | 1673 |
|
2022
Q2 | $74K | Buy |
3,987
+425
| +12% | +$7.89K | ﹤0.01% | 1708 |
|
2022
Q1 | $78K | Hold |
3,562
| – | – | ﹤0.01% | 1788 |
|
2021
Q4 | $101K | Buy |
3,562
+702
| +25% | +$19.9K | ﹤0.01% | 1675 |
|
2021
Q3 | $60K | Hold |
2,860
| – | – | ﹤0.01% | 2032 |
|
2021
Q2 | $54K | Buy |
2,860
+470
| +20% | +$8.87K | ﹤0.01% | 2123 |
|
2021
Q1 | $37K | Hold |
2,390
| – | – | ﹤0.01% | 2254 |
|
2020
Q4 | $34K | Hold |
2,390
| – | – | ﹤0.01% | 2202 |
|
2020
Q3 | $37K | Hold |
2,390
| – | – | ﹤0.01% | 2021 |
|
2020
Q2 | $42K | Buy |
2,390
+1,438
| +151% | +$25.3K | ﹤0.01% | 1936 |
|
2020
Q1 | $14K | Hold |
952
| – | – | ﹤0.01% | 2363 |
|
2019
Q4 | $24K | Hold |
952
| – | – | ﹤0.01% | 2314 |
|
2019
Q3 | $14K | Hold |
952
| – | – | ﹤0.01% | 2572 |
|
2019
Q2 | $24K | Buy |
952
+378
| +66% | +$9.53K | ﹤0.01% | 2338 |
|
2019
Q1 | $13K | Hold |
574
| – | – | ﹤0.01% | 2591 |
|
2018
Q4 | $17K | Hold |
574
| – | – | ﹤0.01% | 2430 |
|
2018
Q3 | $16K | Buy |
+574
| New | +$16K | ﹤0.01% | 2610 |
|